DIVIDEND ANNOUNCEMENT: Gilead Sciences Inc (NASDAQ:GILD) on 02/04/2021 declared a dividend of $0.7100 per share

Gilead Sciences Inc (NASDAQ:GILD) on 02/04/2021 declared a dividend of $ 0.7100 per share payable on March 30, 2021 to shareholders of record as of March 15, 2021. Dividend amount recorded is an increase of $ 0.03 from last dividend Paid.

Gilead Sciences Inc (NASDAQ:GILD) has paid dividends since 2015, has a current dividend yield of 4.4017357826% and has increased its dividends for 5 successive years.

Gilead Sciences Inc's market cap is $ 80,877,626,560 and has a PE ratio of 66.52. The stock price closed yesterday at $ 64.52 and has a 52 week low/high of $ 56.56 and $ 85.97.

Gilead Sciences is a research-based biopharmaceutical company that discovers, develops and commercializes medicines. Co.'s primary areas of focus include viral diseases, inflammatory and fibrotic diseases and oncology. Co.'s products include: Biktarvy for the treatment of HIV-1 infection in certain patients; Vosevi®, a single tablet regimen of sofosbuvir, velpatasvir and voxilaprevir for the re-treatment of chronic hepatitis C virus infection in adults; Vemlidy® for the treatment of chronic hepatitis B virus infection in adults with compensated liver disease; and Yescarta (axicabtagene ciloleucel) for the treatment of adult patients with relapsed or refractory large B-cell lymphoma.

For more information on Gilead Sciences Inc click here.